Summary for ARTG Entry:
FENTANYL WATSON 100 fentanyl 100 mcg/hr transdermal patch pouch
ARTG entry for
Medis Pharma Pty Ltd
PO Box 6127,North Sydney, NSW, 2059
ARTG Start Date
Drug Safety Evaluation Branch
Conditions applicable to all therapeutic goods as specified in the document "Standard Conditions Applying to Registered or Listed Therapeutic Goods
Under Section 28 of the Therapeutic Goods Act 1989" effective 1 July 1995.
Conditions applicable to the relevant category and class of therapeutic goods as specified in the document "Standard Conditions Applying to Registered
or Listed Therapeutic Goods Under Section 28 of the Therapeutic Goods Act 1989" effective 1 July 1995.
1. FENTANYL WATSON 100 fentanyl 100 mcg/hr transdermal patch pouch
Single Medicine Product
See Product Information and Consumer Medicine Information for this product
Management of chronic pain requiring opioid analgesia.
Additional Product information
Store below 25
Pack Size/Poison information
(S8) Controlled Drug
1. FENTANYL WATSON 100 fentanyl 100 mcg/hr transdermal patch
Drug delivery system, transdermal
Route of Administration
Rectangular, round cornered, transparent and colourless patch with 30 cm2
active surface area contained in a protective pouch made from composite
© Commonwealth of Australia.This work is copyright.You are not permitted to re-transmit, distribute or commercialise the material without obtaining prior
written approval from the Commonwealth.Further details can be found at http://www.tga.gov.au/about/website-copyright.htm.
Page 1 of
Produced at 28.11.2017 at 10:43:19 AEDT
This is not an ARTG Certificate document.
The onus is on the reader to verify the current accuracy of the information on the document subsequent to the date shown.
Visit www.tga.gov.au for contact information